title: Targeted Combinations for Hormone Receptor-Positive Advanced Breast Cancer: Who Benefits?
authors.affiliation: Royal Marsden National Health Service Foundation Trust, London, United Kingdom stephen.johnston@rmh.nhs.uk.
authors.forename: Stephen R D
authors.initials: SR
authors.lastname: Johnston
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D000068338:Everolimus / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D000068338:Everolimus; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone